The RRM domain of human fused in sarcoma protein reveals a non-canonical nucleic acid binding site

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1832, Issue 2, 2013, Pages 375-385

  Liu, Xuehui ^a   Niu, Chunyan ^a   Ren, Jintao ^a,b   Zhang, Jiayu ^c   Xie, Xiaodong ^b   Zhu, Haining ^c   Feng, Wei ^a   Gong, Weimin ^a  

^a INSTITUTE OF BIOPHYSICS   (China)

^b LANZHOU UNIVERSITY   (China)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Amyotrophic lateral sclerosis; Fused in sarcoma; NMR; Nucleic acid binding; RNA recognition motif; Surface plasmon resonance

Indexed keywords

DNA; FUSED IN SARCOMA PROTEIN; LYSINE; MUTANT PROTEIN; RNA;

AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ARTICLE; BINDING AFFINITY; BINDING SITE; CARBON NUCLEAR MAGNETIC RESONANCE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; NITROGEN NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN DOMAIN; PROTEIN LOCALIZATION; PROTEIN RNA BINDING; PROTEIN STRUCTURE; STRUCTURE ACTIVITY RELATION; SURFACE PLASMON RESONANCE;

AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; NUCLEIC ACIDS; RNA-BINDING PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; SURFACE PLASMON RESONANCE;

EID: 84871807395     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2012.11.012     Document Type: Article

References (58)

1. Bertolotti A., Lutz Y., Heard D.J., Chambon P., Tora L. hTAF(II)68, a novel RNA/ssDNA-binding protein with homology to the pro-oncoproteins TLS/FUS and EWS is associated with both TFIID and RNA polymerase II. EMBO J. 1996, 15:5022-5031.
2. Bertolotti A., Melot T., Acker J., Vigneron M., Delattre O., Tora L. EWS, but not EWS-FLI-1, is associated with both TFIID and RNA polymerase II: interactions between two members of the TET family, EWS and hTAFII68, and subunits of TFIID and RNA polymerase II complexes. Mol. Cell. Biol. 1998, 18:1489-1497.
3. Zhou Z., Licklider L.J., Gygi S.P., Reed R. Comprehensive proteomic analysis of the human spliceosome. Nature 2002, 419:182-185.
4. Rappsilber J., Ryder U., Lamond A.I., Mann M. Large-scale proteomic analysis of the human spliceosome. Genome Res. 2002, 12:1231-1245.
5. Tan A.Y., Manley J.L. TLS inhibits RNA polymerase III transcription. Mol. Cell. Biol. 2010, 30:186-196.
6. Guipaud O., Guillonneau F., Labas V., Praseuth D., Rossier J., Lopez B., Bertrand P. An in vitro enzymatic assay coupled to proteomics analysis reveals a new DNA processing activity for Ewing sarcoma and TAF(II)68 proteins. Proteomics 2006, 6:5962-5972.
7. Kanai Y., Dohmae N., Hirokawa N. Kinesin transports RNA: isolation and characterization of an RNA-transporting granule. Neuron 2004, 43:513-525.
8. Law W.J., Cann K.L., Hicks G.G. TLS, EWS and TAF15: a model for transcriptional integration of gene expression. Brief Func. Genom. Proteomic 2006, 5:8-14.
9. Vance C., Rogelj B., Hortobagyi T., De Vos K.J., Nishimura A.L., Sreedharan J., Hu X., Smith B., Ruddy D., Wright P., Ganesalingam J., Williams K.L., Tripathi V., Al-Saraj S., Al-Chalabi A., Leigh P.N., Blair I.P., Nicholson G., de Belleroche J., Gallo J.M., Miller C.C., Shaw C.E. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 2009, 323:1208-1211.
10. Kwiatkowski T.J., Bosco D.A., Leclerc A.L., Tamrazian E., Vanderburg C.R., Russ C., Davis A., Gilchrist J., Kasarskis E.J., Munsat T., Valdmanis P., Rouleau G.A., Hosler B.A., Cortelli P., de Jong P.J., Yoshinaga Y., Haines J.L., Pericak-Vance M.A., Yan J., Ticozzi N., Siddique T., McKenna-Yasek D., Sapp P.C., Horvitz H.R., Landers J.E., Brown R.H. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 2009, 323:1205-1208.
11. Lagier-Tourenne C., Polymenidou M., Cleveland D.W. TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration. Hum. Mol. Genet. 2010, 19:R46-64.
12. Dormann D., Haass C. TDP-43 and FUS: a nuclear affair. Trends. Neurosci. 2011, 34:339-348.
13. Lagier-Tourenne C., Cleveland D.W. Rethinking ALS: the FUS about TDP-43. Cell 2009, 136:1001-1004.
14. Calvio C., Neubauer G., Mann M., Lamond A.I. Identification of hnRNP P2 as TLS/FUS using electrospray mass spectrometry. RNA 1995, 1:724-733.
15. Zinszner H., Sok J., Immanuel D., Yin Y., Ron D. TLS (FUS) binds RNA in vivo and engages in nucleo-cytoplasmic shuttling. J. Cell. Sci. 1997, 110(Pt 15):1741-1750.
16. Perrotti D., Bonatti S., Trotta R., Martinez R., Skorski T., Salomoni P., Grassilli E., Lozzo R.V., Cooper D.R., Calabretta B. TLS/FUS, a pro-oncogene involved in multiple chromosomal translocations, is a novel regulator of BCR/ABL-mediated leukemogenesis. EMBO J. 1998, 17:4442-4455.
17. Baechtold H., Kuroda M., Sok J., Ron D., Lopez B.S., Akhmedov A.T. Human 75-kDa DNA-pairing protein is identical to the pro-oncoprotein TLS/FUS and is able to promote D-loop formation. J. Biol. Chem. 1999, 274:34337-34342.
18. Wang X., Arai S., Song X., Reichart D., Du K., Pascual G., Tempst P., Rosenfeld M.G., Glass C.K., Kurokawa R. Induced ncRNAs allosterically modify RNA-binding proteins in cis to inhibit transcription. Nature 2008, 454:126-130.
19. Lerga A., Hallier M., Delva L., Orvain C., Gallais I., Marie J., Moreau-Gachelin F. Identification of an RNA binding specificity for the potential splicing factor TLS. J. Biol. Chem. 2001, 276:6807-6816.
20. Takahama K., Arai S., Kurokawa R., Oyoshi T. Identification of DNA binding specificity for TLS. Nucleic Acids Symp. Ser. (Oxf) 2009, 247-248.
21. Iko Y., Kodama T.S., Kasai N., Oyama T., Morita E.H., Muto T., Okumura M., Fujii R., Takumi T., Tate S., Morikawa K. Domain architectures and characterization of an RNA-binding protein, TLS. J. Biol. Chem. 2004, 279:44834-44840.
22. Morohoshi F., Ootsuka Y., Arai K., Ichikawa H., Mitani S., Munakata N., Ohki M. Genomic structure of the human RBP56/hTAFII68 and FUS/TLS genes. Gene 1998, 221:191-198.
23. Prasad D.D., Ouchida M., Lee L., Rao V.N., Reddy E.S. TLS/FUS fusion domain of TLS/FUS-erg chimeric protein resulting from the t(16;21) chromosomal translocation in human myeloid leukemia functions as a transcriptional activation domain. Oncogene 1994, 9:3717-3729.
24. Crozat A., Aman P., Mandahl N., Ron D. Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma. Nature 1993, 363:640-644.
25. Voigt A., Herholz D., Fiesel F.C., Kaur K., Müller D., Karsten P., Weber S.S., Kahle P.J., Marquardt T., Schulz J.B. TDP-43-mediated neuron loss in vivo requires RNA-binding activity. PLoS One 2010, 5:e12247.
26. Freibaum B., Smith R., Alami N., Taylor P.J. Characterizing the role of TDP-43 in ALS. Proceedings of the 21st International Symposium on ALS/MND 2010, C6.
27. Clery A., Blatter M., Allain F.H. RNA recognition motifs: boring? Not quite. Curr. Opin. Struct. Biol. 2008, 18:290-298.
28. Dreyfuss G., Swanson M.S., Pinol-Roma S. Heterogeneous nuclear ribonucleoprotein particles and the pathway of mRNA formation. Trends. Biochem. Sci. 1988, 13:86-91.
29. 15N spectra of proteins: heteronuclear triple-resonance three-dimensional NMR spectroscopy. Appl. calmodulin Biochem. 1990, 29:4659-4667.
30. Bax A., Ikura M., Kay L.E., Barbato G., Spera S. Multidimensional triple resonance NMR spectroscopy of isotopically uniformly enriched proteins: a powerful new strategy for structure determination. CIBA Found. Symp. 1991, 161:108-119. (discussion 119-135).
31. 13C enriched proteins. J. Biomol. NMR 1991, 1:99-104.
32. Delaglio F., Grzesiek S., Vuister G.W., Zhu G., Pfeifer J., Bax A. NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR 1995, 6:277-293.
33. Brunger A.T., Adams P.D., Clore G.M., DeLano W.L., Gros P., Grosse-Kunstleve R.W., Jiang J.S., Kuszewski J., Nilges M., Pannu N.S., Read R.J., Rice L.M., Simonson T., Warren G.L. Crystallography & NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr. D: Biol. Crystallogr. 1998, 54:905-921.
34. Brunger A.T. Version 1.2 of the Crystallography and NMR system. Nat. Protoc. 2007, 2:2728-2733.
35. Cornilescu G., Delaglio F., Bax A. Protein backbone angle restraints from searching a database for chemical shift and sequence homology. J. Biomol. NMR 1999, 13:289-302.
36. Koradi R., Billeter M., Wuthrich K. MOLMOL: a program for display and analysis of macromolecular structures. J. Mol. Graph. 1996, 14:51-55. (29-32).
37. Gal J., Zhang J., Kwinter D.M., Zhai J., Jia H., Jia J., Zhu H. Nuclear localization sequence of FUS and induction of stress granules by ALS mutants. Neurobiol Aging 2011, 32:2323.e27-2323.e40.
38. Enokizono Y., Konishi Y., Nagata K., Ouhashi K., Uesugi S., Ishikawa F., Katahira M. Structure of hnRNP D complexed with single-stranded telomere DNA and unfolding of the quadruplex by heterogeneous nuclear ribonucleoprotein D. J. Biol. Chem. 2005, 280:18862-18870.
39. Ding J., Hayashi M.K., Zhang Y., Manche L., Krainer A.R., Xu R.M. Crystal structure of the two-RRM domain of hnRNP A1 (UP1) complexed with single-stranded telomeric DNA. Genes Dev. 1999, 13:1102-1115.
40. Kuo P.H., Doudeva L.G., Wang Y.T., Shen C.K., Yuan H.S. Structural insights into TDP-43 in nucleic-acid binding and domain interactions. Nucleic Acids Res. 2009, 37:1799-1808.
41. Li W., Wu P., Ohmichi T., Sugimoto N. Characterization and thermodynamic properties of quadruplex/duplex competition. FEBS Lett. 2002, 526:77-81.
42. Balagurumoorthy P., Brahmachari S.K., Mohanty D., Bansal M., Sasisekharan V. Hairpin and parallel quartet structures for telomeric sequences. Nucleic Acids Res. 1992, 20:4061-4067.
43. Bosco D.A., Lemay N., Ko H.K., Zhou H., Burke C., Kwiatkowski T.J., Sapp P., McKenna-Yasek D., Brown R.H., Hayward L.J. Mutant FUS proteins that cause amyotrophic lateral sclerosis incorporate into stress granules. Hum Mol Genet 2010, 19:4160-4175.
44. Dormann D., Rodde R., Edbauer D., Bentmann E., Fischer I., Hruscha A., Than M.E., Mackenzie I.R., Capell A., Schmid B., Neumann M., Haass C. ALS-associated fused in sarcoma (FUS) mutations disrupt Transportin-mediated nuclear import. EMBO J. 2010, 29:2841-2857.
45. Xia R., Liu Y., Yang L., Gal J., Zhu H., Jia J. Motor neuron apoptosis and neuromuscular junction perturbation are prominent features in a Drosophila model of Fus-mediated ALS. Mol. Neurodegener. 2012, 7:10.
46. Tollervey J.R., Curk T., Rogelj B., Briese M., Cereda M., Kayikci M., Konig J., Hortobagyi T., Nishimura A.L., Zupunski V., Patani R., Chandran S., Rot G., Zupan B., Shaw C.E., Ule J. Characterizing the RNA targets and position-dependent splicing regulation by TDP-43. Nat Neurosci 2011, 14:452-458.
47. Polymenidou M., Lagier-Tourenne C., Hutt K.R., Huelga S.C., Moran J., Liang T.Y., Ling S.C., Sun E., Wancewicz E., Mazur C., Kordasiewicz H., Sedaghat Y., Donohue J.P., Shiue L., Bennett C.F., Yeo G.W., Cleveland D.W. Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Nat Neurosci 2011, 14:459-468.
48. Hoell J.I., Larsson E., Runge S., Nusbaum J.D., Duggimpudi S., Farazi T.A., Hafner M., Borkhardt A., Sander C., Tuschl T. RNA targets of wild-type and mutant FET family proteins. Nat. Struct. Mol. Biol. 2011, 18:1428-1431.
49. Lagier-Tourenne C., Polymenidou M., Hutt K.R., Vu A.Q., Baughn M., Huelga S.C., Clutario K.M., Ling S.C., Liang T.Y., Mazur C., Wancewicz E., Kim A.S., Watt A., Freier S., Hicks G.G., Donohue J.P., Shiue L., Bennett C.F., Ravits J., Cleveland D.W., Yeo G.W. Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs. Nat. Neurosci. 2012, 15:1488-1497.
50. Tan A.Y., Riley T.R., Coady T., Bussemaker H.J., Manley J.L. TLS/FUS (translocated in liposarcoma/fused in sarcoma) regulates target gene transcription via single-stranded DNA response elements. Proc. Natl. Acad. Sci. 2012, 109:6030-6035.
51. Couthouis J., Hart M.P., Shorter J., Dejesus-Hernandez M., Erion R., Oristano R., Liu A.X., Ramos D., Jethava N., Hosangadi D., Epstein J., Chiang A., Diaz Z., Nakaya T., Ibrahim F., Kim H.J., Solski J.A., Williams K.L., Mojsilovic-Petrovic J., Ingre C., Boylan K., Graff-Radford N.R., Dickson D.W., Clay-Falcone D., Elman L., McCluskey L., Greene R., Kalb R.G., Lee V.M., Trojanowski J.Q., Ludolph A., Robberecht W., Andersen P.M., Nicholson G.A., Blair I.P., King O.D., Bonini N.M., Van Deerlin V., Rademakers R., Mourelatos Z., Gitler A.D. A yeast functional screen predicts new candidate ALS disease genes. Proc Natl Acad Sci U S A 2011, 108:20881-20890.
52. Neumann M., Bentmann E., Dormann D., Jawaid A., DeJesus-Hernandez M., Ansorge O., Roeber S., Kretzschmar H.A., Munoz D.G., Kusaka H., Yokota O., Ang L.C., Bilbao J., Rademakers R., Haass C., Mackenzie I.R. FET proteins TAF15 and EWS are selective markers that distinguish FTLD with FUS pathology from amyotrophic lateral sclerosis with FUS mutations. Brain 2011, 134:2595-2609.
53. Ticozzi N., Vance C., Leclerc A.L., Keagle P., Glass J.D., McKenna-Yasek D., Sapp P.C., Silani V., Bosco D.A., Shaw C.E., Brown R.H., Landers J.E. Mutational analysis reveals the FUS homolog TAF15 as a candidate gene for familial amyotrophic lateral sclerosis. Am J Med Genet B Neuropsychiatr Genet 2011, 156B:285-290.
54. Zhang T., Delestienne N., Huez G., Kruys V., Gueydan C. Identification of the sequence determinants mediating the nucleo-cytoplasmic shuttling of TIAR and TIA-1 RNA-binding proteins. J. Cell. Sci. 2005, 118:5453-5463.
55. Bayfield M.A., Kaiser T.E., Intine R.V., Maraia R.J. Conservation of a masked nuclear export activity of La proteins and its effects on tRNA maturation. Mol. Cell. Biol. 2007, 27:3303-3312.
56. Cassola A., Frasch A.C. An RNA recognition motif mediates the nucleocytoplasmic transport of a trypanosome RNA-binding protein. J. Biol. Chem. 2009, 284:35015-35028.
57. Tan A.Y., Manley J.L. The TET family of proteins: functions and roles in disease. J. Mol. Cell. Biol. 2009, 1:82-92.
58. Katahira M., Miyanoiri Y., Enokizono Y., Matsuda G., Nagata T., Ishikawa F., Uesugi S. Structure of the C-terminal RNA-binding domain of hnRNP D0 (AUF1), its interactions with RNA and DNA, and change in backbone dynamics upon complex formation with DNA. J. Mol. Biol. 2001, 311:973-988.